Skip to main content
UL

UTI-lizer

Utilizer develops a smart diagnostic tool for point-of-care urinary tract infection (UTI) testing. This system provides healthcare professionals with accurate, clinically relevant test results quickly, often read digitally via a smartphone. The technology aims to decentralize diagnostics, increase efficiency, and combat antibiotic resistance by reducing unnecessary antibiotic prescriptions.

Stockholm, SwedenFounded 202110500+ followers
Updated 4 months ago

Funding

$3.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Current methods for diagnosing urinary tract infections (UTIs) often lead to misdiagnosis and unnecessary antibiotic prescriptions. This overuse of antibiotics contributes to the rise of antimicrobial resistance (AMR) and increases healthcare costs. A significant percentage of UTI diagnoses result in negative urine cultures, indicating that antibiotics are frequently prescribed when not needed.

Solution

UTI-lizer offers a diagnostic testing system designed for point-of-care UTI detection, combining bacterial culture with digital bioassay technologies. This approach aims to provide accurate and clinically relevant results in a timely manner, enabling healthcare professionals to make informed treatment decisions. By delivering rapid and reliable UTI diagnoses, UTI-lizer helps reduce the misuse of antibiotics, combatting antimicrobial resistance and improving patient outcomes. The system is designed for ease of use in near-patient settings, offering advantages for both patients and healthcare providers.

Target Audience

The primary users are healthcare professionals in near-patient settings, such as clinics and urgent care facilities, who require rapid and accurate UTI diagnoses.

Features

  • Combines bacterial culture and digital bioassay for enhanced sensitivity and specificity, approaching the gold standard for UTI testing.
  • Digital bioassay technology provides enhanced precision with multiplexing capability to reduce human errors.
  • Innovative design assists ease of use at the point-of-care, shortening results waiting time.
  • Enables faster results at the point of care, decentralizing diagnostics.
  • Designed to be cost-effective, increasing efficiency in UTI testing.
This profile is AI-generated and may contain inaccuracies.